|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Intangible digital assets | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Non-current assets | ||||||||||||||||||||
| Property and equipment, at cost, net | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Deficit | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total accounts payable | ||||||||||||||||||||
| Accrued expenses and other payables | ||||||||||||||||||||
| Loans payable | ||||||||||||||||||||
| Security deposit | ||||||||||||||||||||
| Note payable, related party | ||||||||||||||||||||
| Nonrelated Party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Convertible note payable, net of discount | ||||||||||||||||||||
| Operating lease liability | ||||||||||||||||||||
| Warrant derivative liability | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Common stock to be issued | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Non-current liabilities | ||||||||||||||||||||
| Operating lease liability long-term | ||||||||||||||||||||
| Convertible note payable, net of unamortized discount of $0 and $44 | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ Deficit | ||||||||||||||||||||
| Preferred stock value | ||||||||||||||||||||
| Series D Preferred Stock | ||||||||||||||||||||
| Series E Preferred Stock | ||||||||||||||||||||
| Total preferred stock value | ||||||||||||||||||||
| Common stock, $0.001 par value; 10,000,000,000 shares authorized; 6,265,802,029 and 4,640,670,903 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively. | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ deficit | ||||||||||||||||||||
| Total Liabilities and Stockholders’ Deficit | ||||||||||||||||||||
Loading...
